HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    • #Personal Health
  • Newletter
  • Events
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS
    • Home
    • #Global Trends
    • #Vietnam
    • #M&A
    • #Regulations
    • #Knowledge
      • #Corporate Wellness
      • #Human Resources
      • #Capability Development
      • #Personal Health
    • Newletter
    • Events

    Category: Uncategorized

    Primary Healthcare Coverage Expansion: Ministry of Health Plans to Expand VHI Reimbursement for Nearly 350 Drugs at Commune Health Stations

    12/08/2026 Published by Pharma Biz

    Key Development In response to voter inquiries regarding the limited availability of insured pharmaceuticals at primary healthcare facilities, Minister of... Read more

    Category: Uncategorized
    Tags: #Vietnam

    Municipal Healthcare Regulatory Enforcement: Hai Phong Identifies 302 Unlicensed Medical Facilities, Mandating National Data Digitization by August 31, 2026

    12/08/2026 Published by Pharma Biz

    Key Development The Hai Phong Department of Health has officially released the results of a comprehensive municipal healthcare audit, identifying... Read more

    Category: Uncategorized
    Tags: #Vietnam

    Regional Healthcare Export Modernization: Ministry of Health Releases Draft Medical Tourism Master Plan 2026–2030, Targeting 750,000 International Patients and $2.5 Billion Revenue

    12/08/2026 Published by Pharma Biz

    Key Development This morning, August 12, 2026, the Ministry of Health (MOH) of Vietnam formally initiated public and stakeholder consultations... Read more

    Category: Uncategorized
    Tags: #Vietnam

    Vulnerable Healthcare Infrastructure Expansion: Ho Chi Minh City Plans New 2,000-Bed Psychiatric Hospital and Rehabilitation Complex, Directing Emergency Relocation of Pediatric Care Units

    12/08/2026 Published by Pharma Biz

    Key Development On the morning of August 11, 2026, a delegation from the Ho Chi Minh City Party Committee led... Read more

    Category: Uncategorized
    Tags: #Vietnam

    Expanding Ophthalmic Biosimilar Footprint: Samsung Bioepis Officially Launches Opuviz® (Aflibercept Biosimilar) Pre-Filled Syringe Across Europe

    11/08/2026 Published by Pharma Biz

    Key Development South Korean biopharmaceutical major Samsung Bioepis Co., Ltd. officially announced the commercial availability of the pre-filled syringe (PFS)... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Domestic Biomanufacturing Infrastructure Expansion: Bristol Myers Squibb Selects Houston’s Generation Park for $2.3 Billion Multi-Modal Manufacturing Campus

    11/08/2026 Published by Pharma Biz

    Key Development Biopharmaceutical major Bristol Myers Squibb (NYSE: BMY) has officially selected Generation Park in Houston, Texas, as the site... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Domestic Biomanufacturing Expansion: Bristol Myers Squibb Commits $2.3 Billion to Build High-Tech Manufacturing Campus in Houston, Texas

    11/08/2026 Published by Pharma Biz

    Key Development American biopharmaceutical leader Bristol Myers Squibb (NYSE: BMY) has officially announced a $2.3 billion investment to construct a... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Greater China Commercial Expansion: Innovent Biologics and Daiichi Sankyo Sign Exclusive Commercialization Agreement for Vanflyta® in China

    11/08/2026 Published by Pharma Biz

    Key Development Biopharmaceutical major Innovent Biologics, Inc. (HKEX: 1801) and Japanese pharmaceutical company Daiichi Sankyo Company, Limited (TSE: 4568) have... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Rare Oncology Licensing Agreement: Sobi Secures Global Rights to Innate Pharma’s Lacutamab in Up to $580 Million Deal Targeting Cutaneous T-Cell Lymphoma (CTCL)

    11/08/2026 Published by Pharma Biz

    Key Development Swedish rare disease specialist Swedish Orphan Biovitrum (Sobi) has executed an exclusive global licensing agreement valued at up... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Posts pagination

    Previous page Page 1 … Page 39 Page 40 Page 41 … Page 225 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved